Apotex competitive analysis

Latest publications and patents of Apotex New

Explore the latest publications and patents granted to Apotex, showcasing their recent innovations and technological advancements.

Last updated on: Sep 28, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Apotex

Apr 1, 2009A New Use For DeferiproneRevoked

Explore Apotex's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Apr 1, 2009A New Use For Deferiprone2

Latest PTAB cases involving Apotex

Discover the latest PTAB cases involving Apotex, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 4, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Apotex

IPR2025-01531Sep 12, 2025APOTEXPending
IPR2025-00514Jan 30, 2025APOTEXALKERMES PHARMA IRELANDDiscretionary Denial
IPR2024-00631Mar 1, 2024APOTEXNOVO NORDISKTerminated-Settled
IPR2023-00512Feb 10, 2023APOTEXCELGENETerminated-Settled
IPR2022-01524Sep 9, 2022APOTEXREGENERON PHARMACEUTICALSInstitution Denied
IPR2022-00298Dec 9, 2021APOTEXREGENERON PHARMACEUTICALSFinal Written Decision
IPR2022-00301Dec 9, 2021APOTEXREGENERON PHARMACEUTICALSFinal Written Decision
IPR2021-01507Sep 8, 2021APOTEXAUSPEX PHARMACEUTICALSInstitution Denied
IPR2021-01132Jun 17, 2021APOTEXPFIZERTerminated-Settled
IPR2019-00400Dec 13, 2018APOTEXUCB BIOPHARMAFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Apotex with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
APOTEX - 236 - Highly Aggressive
ALCON RESEARCH - 1418Defensive
ALLERGAN11281333Balanced
ELI LILLY4251715Balanced